Claims
- 1. A nutritional composition for the treatment of connective tissue in mammals comprising: a therapeutically effective amount of a glucosamine salt, chondroitin sulfate, collagen and sodium hyaluronate.
- 2. The nutritional composition according to claim 1, wherein the glucosamine salt is selected from the group consisting of glucosamine hydrochloride, glucosamine sulfate, glucosamine nitrate and glucosamine iodide.
- 3. The nutritional composition according to claim 1, wherein the collagen is hydrolyzed collagen.
- 4. The nutritional composition according to claim 3, wherein the hydrolyzed collagen is hydrolyzed Type 1 collagen having a molecular weight average up to 10,000 Daltons.
- 5. The nutritional composition according to claim 1, further comprising a manganese salt.
- 6. The nutritional composition according to claim 5, wherein the manganese salt is manganese ascorbate.
- 7. The nutritional composition according to claim 1, further comprising a detoxifying agent.
- 8. The nutritional composition according to claim 7, wherein the detoxifying agent is L-malic acid.
- 9. The nutritional composition according to claim 1, further comprising an anti-inflammatory agent.
- 10. The nutritional composition according to claim 9, wherein the an anti-inflammatory agent is selected from the group consisting of methy sulfonyl methane and cetyl myristoleate.
- 11. The nutritional composition according to claim 1, further comprising an analgesic.
- 12. The nutritional composition according to claim 11, wherein the analgesic is aspirin.
- 13. The nutritional composition according to claim 1, further comprising a vitamin selected from the group consisting of Vitamin C and Vitamin B12.
- 14. The nutritional composition according to claim 1, wherein the composition is formulated into a unit dosage form for oral administration.
- 15. The nutritional composition according to claim 1, wherein the composition is combined with a suitable pharmaceutical carrier and prepared as a gel, paste or cream for topical application.
- 16. The nutritional composition according to claim 1, wherein the composition is formulated in a solution or suitable pharmaceutical diluent for oral or parenteral administration.
- 17. The nutritional composition according to claim 1, wherein the composition comprises, based on mg/kg of bodyweight:
about 1-30 mg/kg of a glucosamine salt; about 1-15 mg/kg of chondroitin sulfate; about 1-30 mg/kg of collagen; and about 1-15 mg/kg of sodium hyaluronate.
- 18. The nutritional composition according to claim 17, further including a manganese salt ranging from about 0.05 to about 8 mg/kg.
- 19. The nutritional composition according to claim 17, further including L-malic acid ranging from about 0.05 to about 8 mg/kg.
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application is a continuation-in-part of application Ser. No. 09/360,169 filed Jul. 26, 1999, which is a continuation-in-part of application Ser. No. 09/046,710 filed Mar. 24, 1998, and now abandoned.
Continuation in Parts (2)
|
Number |
Date |
Country |
Parent |
09360169 |
Jul 1999 |
US |
Child |
10287590 |
Nov 2002 |
US |
Parent |
09046710 |
Mar 1998 |
US |
Child |
09360169 |
Jul 1999 |
US |